These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16080460)

  • 1. Pharmacokinetics of therapeutic monoclonal antibodies used in oncology.
    Levêque D; Wisniewski S; Jehl F
    Anticancer Res; 2005; 25(3c):2327-43. PubMed ID: 16080460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interaction studies of therapeutic proteins or monoclonal antibodies.
    Mahmood I; Green MD
    J Clin Pharmacol; 2007 Dec; 47(12):1540-54. PubMed ID: 17962422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationization of monoclonal antibodies: another step towards the "magic bullet"?
    Vaisitti T; Deaglio S; Malavasi F
    J Biol Regul Homeost Agents; 2005; 19(3-4):105-12. PubMed ID: 16602624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-based strategy for the assessment of pharmacokinetic drug-drug interactions for therapeutic monoclonal antibodies.
    Zhou H; Davis HM
    Drug Discov Today; 2009 Sep; 14(17-18):891-8. PubMed ID: 19520183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody pharmacokinetics and pharmacodynamics.
    Wang W; Wang EQ; Balthasar JP
    Clin Pharmacol Ther; 2008 Nov; 84(5):548-58. PubMed ID: 18784655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of charge on antibody tissue distribution and pharmacokinetics.
    Boswell CA; Tesar DB; Mukhyala K; Theil FP; Fielder PJ; Khawli LA
    Bioconjug Chem; 2010 Dec; 21(12):2153-63. PubMed ID: 21053952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacokinetics of monoclonal antibodies].
    Keizer RJ; Huitema AD; Damen CW; Schellens JH; Beijnen JH
    Ned Tijdschr Geneeskd; 2007 Mar; 151(12):683-8. PubMed ID: 17447593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination mechanisms of therapeutic monoclonal antibodies.
    Tabrizi MA; Tseng CM; Roskos LK
    Drug Discov Today; 2006 Jan; 11(1-2):81-8. PubMed ID: 16478695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and ADME characterizations of antibody-drug conjugates.
    Lin K; Tibbitts J; Shen BQ
    Methods Mol Biol; 2013; 1045():117-31. PubMed ID: 23913144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of the therapeutic use of monoclonal antibodies in oncology.
    Fridman WH
    C R Biol; 2006 Apr; 329(4):255-9. PubMed ID: 16644495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy.
    Ran Y; Hu H; Hu D; Zhou Z; Sun Y; Yu L; Sun L; Pan J; Liu J; Liu T; Yang Z
    Clin Cancer Res; 2008 Oct; 14(20):6538-45. PubMed ID: 18927294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?
    Deng R; Jin F; Prabhu S; Iyer S
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):141-60. PubMed ID: 22248267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of voriconazole.
    Levêque D; Nivoix Y; Jehl F; Herbrecht R
    Int J Antimicrob Agents; 2006 Apr; 27(4):274-84. PubMed ID: 16563707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug interactions in medical oncology].
    Ishiguro H; Koshiji M; Morizane T; Taniai H; Enatsu S; Fujimoto T; Nambu Y
    Gan To Kagaku Ryoho; 2009 May; 36(5):879-85. PubMed ID: 19461200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy.
    Zhang Q; Chen G; Liu X; Qian Q
    Cell Res; 2007 Feb; 17(2):89-99. PubMed ID: 17242688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of rituximab and its clinical use: thought for the best use?
    Cartron G; Blasco H; Paintaud G; Watier H; Le Guellec C
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):43-52. PubMed ID: 17287129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic antibody targeting of CD97 in experimental arthritis: the role of antigen expression, shedding, and internalization on the pharmacokinetics of anti-CD97 monoclonal antibody 1B2.
    de Groot DM; Vogel G; Dulos J; Teeuwen L; Stebbins K; Hamann J; Owens BM; van Eenennaam H; Bos E; Boots AM
    J Immunol; 2009 Sep; 183(6):4127-34. PubMed ID: 19717518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.
    Loisel S; Ohresser M; Pallardy M; Daydé D; Berthou C; Cartron G; Watier H
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):34-42. PubMed ID: 17197192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
    Amadori S; Stasi R
    Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.